Addition of granulocyte-colony stimulating factor (G-CSF) to adjuvant treatment may increase survival in patients with operable breast cancer: interaction of G-CSF with dormant micrometastatic breast cancer cells
- 31 December 2004
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 63 (1) , 56-58
- https://doi.org/10.1016/j.mehy.2004.01.030
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Work on breast cancer stem cells raises questions about treatment strategies.JNCI Journal of the National Cancer Institute, 2003
- Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741Journal of Clinical Oncology, 2003
- Breast cancer stem cells revealedProceedings of the National Academy of Sciences, 2003
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- Filgrastim (r-metHuG-CSF): the first 10 yearsBlood, 1996